Your browser doesn't support javascript.
loading
Cytokine release syndrome and relevant factors of CD19 targeted chimeric antigen receptor T cell therapy in relapsed/refractory B cell hematological malignancies.
Xu, Qian-Wen; Xu, Hui; Xue, Lei; Wang, Li; Zhang, Xu-Han; Song, Kai-di; Yao, Wen; Wan, Xiang; Tong, Juan; Liu, Hui-Lan; Liu, Xin; Zhu, Xiao-Yu; Sun, Zi-Min; Wang, Xing-Bing.
Afiliação
  • Xu QW; Department of Hematology, The First Affiliated Hospital of USCT (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Xu H; Department of Hematology, The First Affiliated Hospital of USCT (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Xue L; Department of Hematology, The First Affiliated Hospital of USCT (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Wang L; Department of Hematology, The First Affiliated Hospital of USCT (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Zhang XH; Department of Hematology, The First Affiliated Hospital of USCT (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Song KD; Department of Hematology, The First Affiliated Hospital of USCT (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Yao W; Department of Hematology, The First Affiliated Hospital of USCT (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Wan X; Department of Hematology, The First Affiliated Hospital of USCT (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Tong J; Department of Hematology, The First Affiliated Hospital of USCT (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Liu HL; Department of Hematology, The First Affiliated Hospital of USCT (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Liu X; Department of Hematology, The First Affiliated Hospital of USCT (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Zhu XY; Department of Hematology, The First Affiliated Hospital of USCT (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Sun ZM; Department of Hematology, The First Affiliated Hospital of USCT (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Wang XB; Department of Hematology, The First Affiliated Hospital of USCT (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China. Electronic address: wangxingbing@ustc.edu.cn.
Transfus Apher Sci ; 61(6): 103473, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35672235
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores de Antígenos Quiméricos Limite: Humans Idioma: En Revista: Transfus Apher Sci Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores de Antígenos Quiméricos Limite: Humans Idioma: En Revista: Transfus Apher Sci Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China